New Study Demonstrates the Ability of myPath® Melanoma to Accurately Classify Lesions Ruled Indeterminate by Standard Pathological Assessment

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs